Trial Profile
Pharmacokinetics of Doripenem in Critically Ill Patients receiving Continuous Veno-Venous Haemodialfiltration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Doripenem (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 18 Jul 2013 Status changed from not yet recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
- 28 Feb 2011 New trial record